Completed PHASE4 INTERVENTIONAL 2-arm NCT00786136

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes (TRACK-D)

Multicenter Randomized Controlled Study of Rosuvastatin for Prevention of Contrast Induced Acute Kidney Injury in Patients With Diabetes and Slight to Moderate Renal Insufficient

Sponsor: Shenyang Northern Hospital

Conditions Chronic Kidney Disease Diabetes Mellitus

Interventions rosuvastatin

Updated 6 times since 2017 Last updated: Apr 9, 2013 Started: Dec 31, 2008 Primary completion: Oct 31, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Kidney Disease and Diabetes Mellitus, this trial is completed. The trial is conducted by Shenyang Northern Hospital and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shenyang Northern Hospital

Data source: Shenyang Northern Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anshan, China , Baoding, China , Baotou, China , Beijing, China , Cangzhou, China , Changchun, China , Chengdu, China , Chongqing, China , Dalian, China , Dongguan, China and 20 more locations